FX Viewpoint | USD-RMB: More two-way movement, not a downtrend | Article – HSBC VisionGo
- The recent measures and comments out of China suggest a policy preference for broad RMB stability, in our view
- Cyclical developments, such as slowing growth and narrowing yield advantage, may weigh on FX inflows
- We expect USD-RMB to have more two-way movement and then rise slightly later this year
China’s FX policy strives for broad RMB stability
USD-RMB broke the 6.40 level in late May (Bloomberg, 3 June 2021). We believe the recent comments and countercyclical measures out of China (with some examples listed below) suggest that, while there is no line in the sand, there is still a policy preference for basic stability of the RMB exchange rate.
- On 31 May, the People’s Bank of China’s (PBOC) announced that the required-reserve ratio on financial institutions’ foreign currency deposits will be increased from 5% to 7%, effective 15 June 2021. This is the first hike since May 2007 when the RMB was facing strong appreciation pressures after the 2005 de-peg.
- On 23 May, the PBOC reiterated that it will maintain the exchange rate at “basically stable” levels, according to PBOC Vice Governor Liu Guoqiang in a Q&A segment posted on the PBOC’s website. Subsequently, the PBOC issued another statement on 27 May on its website, which stated that under the current RMB FX mechanism, the exchange rate will not be used to stimulate exports (via depreciation) or tackle rising commodity prices (via appreciation).
Slower growth, smaller yield advantage, and narrower current account surplus may weigh on FX inflows in 2H21
We do not believe the recent downward momentum is the beginning of a long-term RMB appreciation trend. Cyclical indicators are pointing to a likely slowdown of GDP growth and smaller yield advantage for China in 2H21. China’s current account surplus is already narrowing, amid deteriorating terms of trade (due to high commodity prices). In 2H21, demand for China’s exports could moderate, as developed markets (DMs) open up and redirect spending to services. COVID-19 developments in other emerging markets (EMs) means exports may also improve by then. We expect these cyclical developments to see net FX flows to China moderating in 2H21.
The Fed’s tapering announcement could come at the end of the year, in our economists’ view
Broad USD weakness may be tested, if the Federal Reserve’s (Fed) tapering debate picks up later in the year and some of the generous USD liquidity conditions could subside later this year. Our economists expect an official tapering announcement at the end of the year and implementation in 2022.
China remains focused on capital account liberalisation
Finally, we think that China’s broad FX framework has not changed, namely two-way capital account liberalisation is maintained with the aim of achieving a balanced flow. Our base case sees USD-RMB exhibiting more two-way movement and then rise slightly later this year, when China’s outbound investment liberalisation accelerates, likely in 2H21.
This document is for information purposes only and should not be regarded as an offer to sell or as a solicitation of an offer to buy the securities or other investment products mentioned in it and/or to participate in any trading strategy. Information in this document is general and should not be construed as investment advice, given it has been prepared without taking account of the objectives, financial situation or needs of any particular investor. Accordingly, investors should, before acting on it, consider the appropriateness of the information, having regard to their objectives, financial situation and needs and, if necessary, seek professional investment and tax advice.
Certain investment products mentioned in this document may not be eligible for sale in some states or countries, and they may not be suitable for all types of investors. Investors should consult with their HSBC representative regarding the suitability of the investment products mentioned in this document and take into account their specific investment objectives, financial situation or particular needs before making a commitment to purchase investment products.
The value of and the income produced by the investment products mentioned in this document may fluctuate, so that an investor may get back less than originally invested. Certain high-volatility investments can be subject to sudden and large falls in value that could equal or exceed the amount invested. Value and income from investment products may be adversely affected by exchange rates, interest rates, or other factors. Past performance of a particular investment product is not indicative of future results.
HSBC and its affiliates will from time to time sell to and buy from customers the securities/instruments (including derivatives) of companies covered here on a principal or agency basis.
Whether, or in what time frame, an update of this information will be published is not determined in advance.
This report is dated as at 04 June 2021.
All market data included in this report are dated as at close 03 June 2021, unless a different date and/or a specific time of day is indicated in the report.
HSBC has procedures in place to identify and manage any potential conflicts of interest that arise in connection with its Research business. HSBC's analysts and its other staff who are involved in the preparation and dissemination of Research operate and have a management reporting line independent of HSBC's Investment Banking business. Information Barrier procedures are in place between the Investment Banking, Principal Trading, and Research businesses to ensure that any confidential and/or price sensitive information is handled in an appropriate manner.
You are not permitted to use, for reference, any data in this document for the purpose of (i) determining the interest payable, or other sums due, under loan agreements or under other financial contracts or instruments, (ii) determining the price at which a financial instrument may be bought or sold or traded or redeemed, or the value of a financial instrument, and/or (iii) measuring the performance of a financial instrument or of an investment fund.